SCHEMBL25817379

SCHEMBL25817379

CC(C)(C)c1nc(-c2ccc3c(c2)sc2ccccc23)nc(C(C)(C)C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HPGD P15428 2/20 0.42
RAB9A P51151 2/20 0.42
GPR3 P46089 1/20 0.41
TNKS O95271 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
TNF P01375 1/20 0.36
NOD1 Q9Y239 1/20 0.36
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN12 Q05209 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23473632 0.93 MAPT (0.40) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL25817382 0.91 GPR3 (0.41) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL25833275 0.88 MAPT (0.36) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL25878025 0.88 GPR3 (0.41) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL25878090 0.86 KDM4E (0.42) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL25878024 0.86 ALOX5 (0.44) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL19977479 0.85 PTPN7 (0.41) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL15315643 0.84 GPR3 (0.54) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL30422699 0.84 GPR3 (0.54) MAPTALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL23473777 0.82 HPGD (0.40) MAPTALDH1A1SMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, AOC2, EPCAM MAPT 1654/4885ALDH1A1 489/4885SMN1; SMN2 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.